COVID-19 lessons
What Imperial research taught us about COVID-19 in 2022
From increased understanding of immunity to analysing the success of vaccines, we look back at what Imperial taught us about COVID-19 in 2022.
Stories tagged with 'vaccines'
REINFECTION DEFENCES
First-line defences against COVID-19 are short-lived and may explain reinfection
A new study finds that antibodies produced in the nose decline 9 months after infection, while those found in the blood last at least a year.
Prof. Osier gets award
Prof. Faith Osier receives prestigious award for her contribution to Immunology
Only two awards were given by the British Society of Immunology (BSI) this year, and Professor Osier is one of recipients.
Feature
disease
Covid won’t be the last pandemic – climate change will make sure of that
As the world warms, infectious diseases will spread – now’s the time to prepare, says Dr Ilaria Dorigatti.
World Polio Day 2022
Why do children need polio vaccine boosters - Q and A
On World Polio Day, we talk to two experts about why polio boosters are needed in London.
GREAT EX RD FESTIVAL
Infectious disease trailblazers inspire Great Exhibition Road Festival-goers
No stranger to trailblazers, the Department of Infectious Disease had a strong presence at the 2022 Great Exhibition Road Festival.
COVID antibodies
Interrupting immune-suppressing treatment can boost COVID vaccine response
A brief interruption in treatment for people who use immune-suppressing medicine can double the antibody response to COVID-19 booster vaccination.
Impact COVID vaccination
Vaccinations may have prevented almost 20 million COVID-19 deaths worldwide
Vaccinations estimated to have averted 19.8 million COVID-19 deaths worldwide in their first year, according to the latest Imperial modelling study.
Feature
Salmonella study
How can a human challenge study help tackle the global impact of Salmonella?
Dr Malick Gibani explains how a human challenge study for non-typhoidal Salmonella can support vaccine development and protect vulnerable populations.
Limited Boost
Omicron infection is a poor booster of COVID-19 immunity
People infected with the Omicron variant show poor immune boosting against future SARS-CoV-2 infection.
10
